Assen Goudev

5.0k total citations · 1 hit paper
37 papers, 408 citations indexed

About

Assen Goudev is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Assen Goudev has authored 37 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Assen Goudev's work include Atrial Fibrillation Management and Outcomes (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Heart Failure Treatment and Management (6 papers). Assen Goudev is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Heart Failure Treatment and Management (6 papers). Assen Goudev collaborates with scholars based in Bulgaria, United States and United Kingdom. Assen Goudev's co-authors include Marc S. Sabatine, Deepak L. Bhatt, Sabina A. Murphy, Eugene Braunwald, Alexander Parkhomenko, Robert F. Storey, Philippe Gabríel Steg, KyungAh Im, Marc P. Bonaca and Elena Kinova and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Assen Goudev

34 papers receiving 396 citations

Hit Papers

Semaglutide and cardiovascular outcomes in patients with ... 2024 2026 2025 2024 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
    2024 100 citations Assen Goudev et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Assen Goudev Bulgaria 9 260 127 110 51 45 37 408
Priyanka Kakar United States 9 145 0.6× 101 0.8× 143 1.3× 53 1.0× 22 0.5× 13 328
Jim Stewart New Zealand 8 225 0.9× 57 0.4× 134 1.2× 34 0.7× 13 0.3× 20 303
Shinji Hisatake Japan 11 251 1.0× 60 0.5× 82 0.7× 41 0.8× 32 0.7× 39 333
Andrea Rivas United States 10 301 1.2× 61 0.5× 152 1.4× 75 1.5× 18 0.4× 20 375
S. D. Kristensen Denmark 7 242 0.9× 46 0.4× 107 1.0× 69 1.4× 11 0.2× 8 368
Payman Shahabi Iran 10 63 0.2× 44 0.3× 55 0.5× 29 0.6× 40 0.9× 26 305
Д. А. Андреев Russia 9 208 0.8× 54 0.4× 37 0.3× 30 0.6× 17 0.4× 76 298
Julie K. Brooks United States 4 234 0.9× 63 0.5× 89 0.8× 47 0.9× 10 0.2× 6 326
Tadao Goto Japan 8 135 0.5× 79 0.6× 90 0.8× 19 0.4× 31 0.7× 14 360
Craig Basman United States 8 225 0.9× 109 0.9× 97 0.9× 25 0.5× 38 0.8× 44 447

Countries citing papers authored by Assen Goudev

Since Specialization
Citations

This map shows the geographic impact of Assen Goudev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assen Goudev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assen Goudev more than expected).

Fields of papers citing papers by Assen Goudev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assen Goudev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assen Goudev. The network helps show where Assen Goudev may publish in the future.

Co-authorship network of co-authors of Assen Goudev

This figure shows the co-authorship network connecting the top 25 collaborators of Assen Goudev. A scholar is included among the top collaborators of Assen Goudev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assen Goudev. Assen Goudev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Kinova, Elena, et al.. (2024). Giant Left Atrium in an Octogenarian with a Complex Etiology. Balkan Medical Journal. 41(3). 226–227. 1 indexed citations
5.
Kinova, Elena, et al.. (2023). Hiatal hernia: the great masquerade in the emergency department. European Journal of Case Reports in Internal Medicine. 10(4). 3834–3834. 1 indexed citations
6.
7.
Oyama, Kazuma, Itamar Raz, Avivit Cahn, et al.. (2021). Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial. European Heart Journal. 43(31). 2958–2967. 49 indexed citations
8.
Magnani, Giulia, Diego Ardissino, KyungAh Im, et al.. (2021). Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction. Journal of the American Heart Association. 10(4). e017008–e017008. 17 indexed citations
9.
Wussler, Desirée, Nikola Kozhuharov, Ivo Strebel, et al.. (2021). Discordance in prognostic ability between physician assessed NYHA classification and self-reported health status in patients with acute heart failure. European Heart Journal. 42(Supplement_1). 1 indexed citations
10.
Wussler, Desirée, Danielle Menosi Gualandro, Samyut Shrestha, et al.. (2021). Effect of a Strategy of Comprehensive Vasodilation Versus Usual Care on Health-Related Quality of Life Among Patients with Acute Heart Failure. ESC Heart Failure. 8(5). 4218–4227. 5 indexed citations
11.
Kozhuharov, Nikola, Desirée Wussler, Thomas E Kaier, et al.. (2021). Cardiac myosin‐binding protein C in the diagnosis and risk stratification of acute heart failure. European Journal of Heart Failure. 23(5). 716–725. 7 indexed citations
12.
Oyama, Kazuma, Itamar Raz, Avivit Cahn, et al.. (2020). EFFECTS OF DAPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES ACROSS BODY MASS INDEX CATEGORIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN THE DECLARE TIMI 58 TRIAL. Journal of the American College of Cardiology. 75(11). 660–660. 3 indexed citations
13.
Ruff, Christian T., Assen Goudev, João Morais, et al.. (2020). Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial. International Journal of Cardiology. 304. 185–191. 20 indexed citations
14.
Kinova, Elena, et al.. (2019). Left Ventricular Strain and Rotation in Patients with Dilated Cardiomyopathy and Severe Systolic Dysfunction. Cardiology. 145(1). 1–12. 1 indexed citations
15.
Bonaca, Marc P., Robert F. Storey, Pierre Théroux, et al.. (2017). Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54. Journal of the American College of Cardiology. 70(11). 1368–1375. 52 indexed citations
16.
17.
Ruff, Christian T., Assen Goudev, João Morais, et al.. (2016). Abstract 16551: Efficacy and Safety of Oral Anticoagulation in 21105 Patients With Atrial Fibrillation Stratified by Diabetic Status in the ENGAGE AF-TIMI 48 Trial. Circulation. 3 indexed citations
18.
Backer, Guy De, et al.. (2011). Design and methodology of POWER, an open‐label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertension. Fundamental and Clinical Pharmacology. 27(2). 210–215. 6 indexed citations
19.
Kinova, Elena, et al.. (2010). The role of biomarkers in early diagnosis of chemotherapy-induced cardiotoxicity.. 41(1). 3–8.
20.
Goudev, Assen, et al.. (2001). Effects of the combined hormonal replacement drug estradiolvalerate/levonorgestrel on climacteric complaints, endometrium andlipid profile of peri- and postmenopausal women. Methods and Findings in Experimental and Clinical Pharmacology. 23(4). 197–197. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priyanka Kakar Breakdown of academic impact, for papers by Jim Stewart Breakdown of academic impact, for papers by Shinji Hisatake Breakdown of academic impact, for papers by Andrea Rivas Breakdown of academic impact, for papers by S. D. Kristensen Breakdown of academic impact, for papers by Payman Shahabi Breakdown of academic impact, for papers by Д. А. Андреев Breakdown of academic impact, for papers by Julie K. Brooks Breakdown of academic impact, for papers by Tadao Goto Breakdown of academic impact, for papers by Craig Basman
Rankless by CCL
2026